Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2020

May 8, 2020

31949_dirs_2020-05-07_fe7de6e2-6eb5-4437-a31c-1ee3179906a0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2020-04-30

Reporting Person: Weinberg Uri (Chief Science Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 2773 Direct
Restricted Share Units 2834 Direct
Restricted Share Units 4205 Direct
Restricted Share Units 14415 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Options to Buy Ordinary Shares $11.46 2026-02-24 Ordinary Shares (8750.0) Direct
Options to Buy Ordinary Shares $7.15 2027-02-21 Ordinary Shares (13000.0) Direct
Options to Buy Ordinary Shares $47.04 2029-03-21 Ordinary Shares (7784.0) Direct
Options to Buy Ordinary Shares $47.56 2029-05-07 Ordinary Shares (7691.0) Direct
Options to Buy Ordinary Shares $69.37 2030-03-02 Ordinary Shares (27794.0) Direct

Footnotes

F1: One-half of these restricted share units are scheduled to vest on each of 3/5/2021 and 3/5/2022, subject to the reporting person's continued employment through such dates.

F2: One-third of these restricted stock units are scheduled to vest on each of 5/8/2020, 5/8/2021 and 5/8/2022, subject to the reporting person's continued employment through such dates.

F3: One-third of these restricted stock units are scheduled to vest on each of 3/3/2021, 3/3/2022 and 3/3/2023, subject to the reporting person's continued employment through such dates.

F4: Fully vested as of the date hereof.

F5: One-half of these options vested or is scheduled to vest on each of 2/22/2020 and 2/22/2021, subject to the reporting person's continued employment through such dates.

F6: One-quarter of these options vested or is scheduled to vest on each of 3/5/2020, 3/5/2021, 3/5/22 and 3/5/2023, subject to the reporting person's continued employment through such dates.

F7: One-quarter of these options vested or is scheduled to vest on each of 5/8/2020, 5/8/2021, 5/8/22 and 5/8/2023, subject to the reporting person's continued employment through such dates.

F8: One-quarter of these options vested or is scheduled to vest on each of 3/3/2021, 3/3/2022, 3/3/23 and 3/3/2024, subject to the reporting person's continued employment through such dates.